Kymanox® Announces F
Kymanox® Announces Facility Expansion to Enhance CGxP Space and Laboratory Service Offerings
June 03, 2024 10:16 ET | Kymanox
King of Prussia, Pennsylvania USA, June 03, 2024 (GLOBE NEWSWIRE) -- Kymanox is pleased to announce the expansion of its device design and testing facility in King of Prussia (KOP), PA, which will...
AAMI_tagline_web.png
New AAMI Guidance on Combination Products and FDA CGMPs
May 30, 2024 08:47 ET | AAMI
Arlington, Virginia, May 30, 2024 (GLOBE NEWSWIRE) -- As the breadth and scope of combination products around the world continues to ramp up, are U.S. manufacturers equipped with the best design...
NEUMA Moves To New Headquarters
NEUMA, The Design And Testing Arm Of Kymanox, Moves To New Headquarters
January 05, 2023 13:00 ET | Kymanox
Morrisville, North Carolina USA and King of Prussia, Pennsylvania USA, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company exclusively serving the life...
Lubrizol expands its medical device design, development, and manufacturing capabilities with the acquisition of Bavaria Medizin Technologie GmbH.
Lubrizol übernimmt die Bavaria Medizin Technologie GmbH
July 15, 2019 02:00 ET | Lubrizol
CLEVELAND, July 15, 2019 (GLOBE NEWSWIRE) -- Die Lubrizol Corporation gibt die Übernahme der Bavaria Medizin Technologie GmbH (BMT), eines innovativen Entwicklers und Herstellers von intravaskulären...
Lubrizol expands its medical device design, development, and manufacturing capabilities with the acquisition of Bavaria Medizin Technologie GmbH.
Lubrizol Acquires Bavaria Medizin Technologie GmbH
July 15, 2019 02:00 ET | Lubrizol
CLEVELAND, July 15, 2019 (GLOBE NEWSWIRE) -- The Lubrizol Corporation announces the acquisition of Bavaria Medizin Technologie GmbH (BMT), an innovative designer and manufacturer of both...